News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference

Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]

Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference

Precigen, Inc. (NASDAQ:PGEN) is definitely on the radar of institutional investors who own 31% of the company [Yahoo! Finance]

Precigen Is Still A Buy After The Papzimeos Rally [Seeking Alpha]

11/13/2025

04:05 pm

pgen

25.6%

MISS

8/12/2025

04:29 pm

pgen

-1.3%

BEAT

5/14/2025

04:05 pm

pgen

2.3%

MISS

Form 4 PRECIGEN, INC. For: Dec 22 Filed by: KIRK RANDAL J

Form 144 PRECIGEN, INC. Filed by: KIRK RANDAL J

Form 4 PRECIGEN, INC. For: Dec 12 Filed by: KINDLER JEFFREY B

Form 144 PRECIGEN, INC. Filed by: KINDLER JEFFREY B

Form SCHEDULE 13D/A PRECIGEN, INC. Filed by: KIRK RANDAL J

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}